ClinicalTrials.Veeva

Menu

Matrix Metalloproteinases in Atherosclerosis of Chronic Kidney Disease (MMACKD)

A

Aristotle University Of Thessaloniki

Status

Unknown

Conditions

Diabetic Nephropathy

Study type

Observational

Funder types

Other

Identifiers

NCT01458158
A13749
31-8-2010 (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to determine whether matrix metalloproteinases are associated with atherosclerosis in the different stages of chronic kidney disease.

Full description

The purpose of this study is to determine the correlation of matrix metalloproteinases and atherosclerosis of chronic kidney disease. Patients with diabetes mellitus type 2,as a non-inflammatory leading cause of end stage renal failure and patients with chronic glomerulonephritis and similar course of proteinuria,as an inflammatory leading cause of end stage renal failure are enrolled.

Enrollment

300 estimated patients

Sex

All

Ages

50 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Chronic kidney disease
  • Diabetes mellitus type 2

Exclusion criteria

  • Malignancy

Trial design

300 participants in 3 patient groups

Diabetic nephropathy
Description:
Diabetic nephropathy in patients with type 2 diabetes
chronic glomerulonephritis
Description:
chronic glomerulonephritis in patients without diabetes mellitus
controls
Description:
participants without diabetic nephropathy and chronic glomerulonephritis

Trial contacts and locations

1

Loading...

Central trial contact

Grigorios G. Dimas

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems